Cargando…

Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa

BACKGROUND: International sustainable development goals for the elimination of viral hepatitis as a public health problem by 2030 highlight the need to optimize strategies for prevention, diagnosis and treatment of hepatitis B virus (HBV) infection. An important priority for Africa is to have afford...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mokaya, Jolynne, Burn, Edward A. O., Tamandjou, Cynthia Raissa, Goedhals, Dominique, Barnes, Eleanor J., Andersson, Monique, Pinedo-Villanueva, Rafael, Matthews, Philippa C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595556/ https://www.ncbi.nlm.nih.gov/pubmed/31242901 http://dx.doi.org/10.1186/s12889-019-7095-4

Ejemplares similares

Hepatitis B virus resistance to tenofovir: fact or fiction? A systematic literature review and structural analysis of drug resistance mechanisms
por: Mokaya, Jolynne, et al.
Publicado: (2020)

A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action
por: Mokaya, Jolynne, et al.
Publicado: (2018)

Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adults
por: Mokaya, Jolynne, et al.
Publicado: (2020)

Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations
por: Mokaya, Jolynne, et al.
Publicado: (2021)

Treatment advantage in HBV/HIV coinfection compared to HBV monoinfection in a South African cohort
por: Maponga, Tongai G., et al.
Publicado: (2020)

A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection - A systematic review
por: Mokaya, Jolynne, et al.
Publicado: (2018)

Hepatitis B virus drug resistance mutations in HIV/HBV co-infected children in Windhoek, Namibia
por: Tamandjou Tchuem, Cynthia Raissa, et al.
Publicado: (2020)

Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study
por: Wang, Tingyan, et al.
Publicado: (2021)

A Study of Knowledge, Experience, and Beliefs About Hepatitis B Virus (HBV) Infection in South Western Uganda
por: Mugisha, Joseph, et al.
Publicado: (2019)

Screening, characterisation and prevention of Hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa
por: Jooste, Pieter, et al.
Publicado: (2016)

Is hepatitis B birth dose vaccine needed in Africa?
por: Tamandjou, Cynthia Raissa, et al.
Publicado: (2017)

Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV)
por: McNaughton, Anna L., et al.
Publicado: (2019)

Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis
por: McNaughton, Anna L., et al.
Publicado: (2020)

Bimodal distribution and set point HBV DNA viral loads in chronic infection: retrospective analysis of cohorts from the UK and South Africa
por: Downs, Louise O., et al.
Publicado: (2020)

Endemic HBV among hospital in-patients in Bangladesh, including evidence of occult infection
por: Chowdhury, Fazle Rabbi, et al.
Publicado: (2021)

Liver function tests and fibrosis scores in a rural population in Africa: a cross-sectional study to estimate the burden of disease and associated risk factors
por: O'Hara, Geraldine, et al.
Publicado: (2020)

Barriers that prevent adults living with HBV infection from participating in clinical research: experience from South Africa
por: Mofokeng, Nombuyiselo, et al.
Publicado: (2023)

HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons
por: Bihl, Florian, et al.
Publicado: (2015)

Distribution Evaluation of Tenofovir in the Breast Milk of Mothers With HBeAg-Positive Chronic HBV Infection After Treatment With Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate by a Sensitive UPLC-MS/MS Method
por: Yang, Na, et al.
Publicado: (2021)

Overview of influenza virus infections in Kenya: past, present and future
por: Matheka, Duncan Mwangangi, et al.
Publicado: (2013)

3-year Treatment of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate for Chronic HBV Infection in China
por: Hou, Jinlin, et al.
Publicado: (2021)

Suppression of HBV by Tenofovir in HBV/HIV Coinfected Patients: A Systematic Review and Meta-Analysis
por: Price, Huw, et al.
Publicado: (2013)

Renal safety of tenofovir and/or entecavir in patients with chronic HBV monoinfection
por: Yang, Young-Mo, et al.
Publicado: (2017)

Effectiveness of tenofovir or telbivudine in preventing HBV vertical transmission for pregnancy
por: Zeng, Jianyong, et al.
Publicado: (2019)

Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta‐analysis
por: Campbell, Cori, et al.
Publicado: (2020)

What Constitutes Protective Immunity Following Yellow Fever Vaccination?
por: Mokaya, Jolynne, et al.
Publicado: (2021)

Characterizing the epidemiology and interaction between HIV-1 and HBV co-infection in South Africa
por: Matthews, Philippa C, et al.
Publicado: (2014)

Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV
por: Pan, Calvin Q., et al.
Publicado: (2021)

Estimating the epidemiology of chronic Hepatitis B Virus (HBV) infection in the UK: what do we know and what are we missing?
por: Campbell, Cori, et al.
Publicado: (2023)

Development of a Transdermal Delivery System for Tenofovir Alafenamide, a Prodrug of Tenofovir with Potent Antiviral Activity Against HIV and HBV
por: Puri, Ashana, et al.
Publicado: (2019)

Third-trimester tenofovir to prevent mother-to-child hepatitis B virus transmission
por: Burman, Blaire E., et al.
Publicado: (2017)

An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression
por: Das, Srijanee, et al.
Publicado: (2022)

Tenofovir vs Entecavir Among Patients With HBV-Related HCC After Resection
por: Li, Pengpeng, et al.
Publicado: (2023)

Therapeutic vaccines in HBV: lessons from HCV
por: Barnes, Eleanor
Publicado: (2015)

Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Tenofovir Disoproxil Fumarate‐Based Antiretroviral Therapy Versus Women With HBV Receiving Tenofovir Disoproxil Fumarate Monotherapy
por: Bukkems, Vera E., et al.
Publicado: (2020)

1591 Hepatitis B outcome in coinfected HIV-HBV individuals in the tenofovir/emtricitabine era
por: Nguyen, Divien, et al.
Publicado: (2014)

FAIR data needed to liberate hepatitis B virus (HBV) from the catch-22 of neglect
por: Matthews, Philippa C
Publicado: (2019)

Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus
por: Zhu, Bo, et al.
Publicado: (2021)

The global burden of Chikungunya fever among children: A systematic literature review and meta-analysis
por: Nyamwaya, Doris K., et al.
Publicado: (2022)

C2729T mutation associated with HBV mother-to-child transmission reduces HBV production via suppressing LHBs expression
por: Liu, Minmin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m20e08hfi9egr73moc520dbhic